Deep Chakrabarti
@deeponco.bsky.social
📤 24
📥 36
📝 3
Locum Consultant Uro-Oncology @royalmarsdenNHS, Keen on Football/Aviation/Cats
@alison-tree.bsky.social
@ccparker.bsky.social
#prostatecancer
#pcsm
add a skeleton here at some point
3 months ago
0
3
2
Happy to share our review on hypo- and ultra-hypofractionation for prostate cancer radiotherapy, just published in Seminars in Radiation Oncology
@alison-tree.bsky.social
@harshanigreen.bsky.social
Full-text link:
authors.elsevier.com/a/1lFrI3lXQo...
3 months ago
0
8
4
Management of Testicular Cancer
@ascocancer.bsky.social
doi.org/10.1200/OP-2...
4 months ago
0
2
0
reposted by
Deep Chakrabarti
Alison Tree
4 months ago
Excited to see the HERMES trial results in print
www.sciencedirect.com/science/arti...
Small trial but toxicity of 2 fractions looks promising at 24/27 Gy, no GI tox of G2 or higher out to 12 weeks @momentumstudy.bsky.social
@icr.ac.uk
loading . . .
HERMES: Randomised trial of 2-fraction or 5-fraction MRI-guided adaptive prostate radiotherapy
To demonstrate safety and feasibility of 2-fraction stereotactic body radiotherapy (SBRT) for prostate cancer.This single centre, non-comparative, pha…
https://www.sciencedirect.com/science/article/pii/S0360301625004766?utm_campaign=STMJ_219742_AUTH_SERV_PA&utm_medium=email&utm_acid=57580864&SIS_ID=&dgcid=STMJ_219742_AUTH_SERV_PA&CMX_ID=&utm_in=DM568979&utm_source=AC_
0
7
3
you reached the end!!
feeds!
log in
